Early Detection Research Network

Breast

No additional breast data available.
http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/902/825
Under Review
Two
CCND1 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.
6774bcad521f4d178ab77fc66aa73791
no
no
Contents
Triple Negative Breast Cancer Team Project

Triple negative breast cancers (TNBC), comprise 15-20% of breast cancers, and are associated with later stage at diagnosis, increased mortality, and occur more frequently in younger women where mammographic screening is less reliable. TNBCs are more likely to be diagnosed by physical exam than by mammographic screening. There is an unmet clinical need for biomarkers for the early detection of TNBC. Here, we are proposing the development of a plasma-based biomarker panel for the routine screening of women over the age of 40 for TNBC that can be used to identify women for further imaging.